1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Sejbal, J. Kotovych, G. Cann, J.R. Stewart, J.M. Gera, L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C6 H15 N4 O2 1 175.209 D-ARGININE D-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C5 H9 N O3 131.130 n 4-HYDROXYPROLINE HYDROXYPROLINE L-peptide linking C11 H13 N O2 191.226 n ALPHA-AMINO-2-INDANACETIC ACID L-peptide linking C9 H15 N O2 169.221 OCTAHYDROINDOLE-2-CARBOXYLIC ACID L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C7 H9 N O2 S 171.217 n BETA(2-THIENYL)ALANINE L-peptide linking US J.Med.Chem. JMCMAR 0151 0022-2623 39 1281 1292 10.1021/jm950485f 8632435 An NMR, CD, molecular dynamics, and fluorometric study of the conformation of the bradykinin antagonist B-9340 in water and in aqueous micellar solutions. 1996 US J.Am.Chem.Soc. JACSAT 0004 0002-7863 116 7532 Combined Approach of NMR and Molecular Dynamics within a Biphasic Membrane Mimetics: Conformation and Orientation of the Bradykinin Antagonist Hoe 140 1994 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1321.574 bradykinin antagonist B-9340 1 syn polymer no yes (DAR)RP(HYP)G(TIH)S(IGL)(OIC)R RRPPGASGXR A polypeptide(L) n n n n n n n n n n repository Initial release Version format compliance Atomic model Database references Derived calculations Non-polymer description Structure summary Version format compliance 1 0 1995-12-07 1 1 2008-03-24 1 2 2011-07-13 Y 1995-07-28 REL 1 MOLECULAR SIMULATIONS,INC refinement BIOGRAF DAR 1 n 1 DAR 1 A ARG 2 n 2 ARG 2 A PRO 3 n 3 PRO 3 A HYP 4 n 4 HYP 4 A GLY 5 n 5 GLY 5 A TIH 6 n 6 TIH 6 A SER 7 n 7 SER 7 A IGL 8 n 8 IGL 8 A OIC 9 n 9 OIC 9 A ARG 10 n 10 ARG 10 A author_defined_assembly 1 monomeric A HYP 4 4-HYDROXYPROLINE A HYP 4 PRO A TIH 6 BETA(2-THIENYL)ALANINE A TIH 6 ALA A IGL 8 ALPHA-AMINO-2-INDANACETIC ACID A IGL 8 GLY 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A GLY TIH 5 6 149.02 1 7.88 0.50 120.30 128.18 A A A NE CZ NH1 DAR DAR DAR 1 1 1 N 1 -6.92 0.50 120.30 113.38 A A A NE CZ NH2 DAR DAR DAR 1 1 1 N 1 4.43 0.50 120.30 124.73 A A A NE CZ NH1 ARG ARG ARG 2 2 2 N 1 -6.00 0.50 120.30 114.30 A A A NE CZ NH2 ARG ARG ARG 2 2 2 N 1 4.63 0.50 120.30 124.93 A A A NE CZ NH1 ARG ARG ARG 10 10 10 N 1 -3.14 0.50 120.30 117.16 A A A NE CZ NH2 ARG ARG ARG 10 10 10 N 1 A PRO 3 -32.35 104.86 1 A TIH 6 173.60 119.46 1 A IGL 8 81.17 -157.12 1 A OIC 9 -93.07 59.25 B9340 AN NMR, CD, MOLECULAR DYNAMICS, AND FLUOROMETRIC STUDY OF THE CONFORMATION OF THE BRADYKININ ANTAGONIST B-9340 IN WATER AND IN AQUEOUS MICELLAR SOLUTIONS 1 Y N covale 1.372 A PRO 3 A C PRO 3 1_555 A HYP 4 A N HYP 4 1_555 covale 1.344 A HYP 4 A C HYP 4 1_555 A GLY 5 A N GLY 5 1_555 covale 1.353 A GLY 5 A C GLY 5 1_555 A TIH 6 A N TIH 6 1_555 covale 1.355 A TIH 6 A C TIH 6 1_555 A SER 7 A N SER 7 1_555 covale 1.350 A SER 7 A C SER 7 1_555 A IGL 8 A N IGL 8 1_555 covale 1.377 A IGL 8 A C IGL 8 1_555 A OIC 9 A N OIC 9 1_555 covale 1.358 A OIC 9 A C OIC 9 1_555 A ARG 10 A N ARG 10 1_555 covale 1.358 A DAR 1 A C DAR 1 1_555 A ARG 2 A N ARG 2 1_555 ANTAGONIST BRADYKININ ANTAGONIST, ANTAGONIST 1BDK PDB 1 1BDK RRPPGASGXR 1 10 1BDK 1 10 1BDK A 1 1 10 BINDING SITE FOR RESIDUE DAR A 1 Software 2 BINDING SITE FOR RESIDUE OIC A 9 Software 3 A ARG 2 A ARG 2 2 1_555 A PRO 3 A PRO 3 2 1_555 A TIH 6 A TIH 6 3 1_555 A SER 7 A SER 7 3 1_555 A IGL 8 A IGL 8 3 1_555 1 P 1